Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
18 avr. 2023 17h30 HE
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO, April 18, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2023 Bloom Burton...
Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
11 avr. 2023 07h25 HE
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO, April 11, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce preliminary revenue estimates for the company’s fourth fiscal quarter...
Medexus Announces New License Deal for Topical Terbinafine
22 mars 2023 07h20 HE
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO, March 22, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that the company has secured Canadian rights to commercialize...
Medexus Announces US$58.5 million in New Credit Facilities
08 mars 2023 17h00 HE
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO, March 08, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; TSX: MDP.DB; OTCQX: MEDXF) today entered into a new senior secured credit agreement agented by BMO. The...
Medexus to Participate in 35th Annual Roth Conference
06 mars 2023 08h00 HE
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO, March 06, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that company management will be participating in the 35th Annual Roth...
Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022
08 févr. 2023 17h00 HE
|
Medexus Pharmaceuticals Inc
Results reflect growth across all leading prescription products, demonstrating continued track record of strong overall performance Management to host conference call at 8:00 AM Eastern Time on...
Medexus Welcomes Two New Board Members
06 févr. 2023 17h00 HE
|
Medexus Pharmaceuticals Inc
Harmony P. Garges MD MPH and Menassie Taddese MBA appointed to Medexus’s board of directors Appointments bolster Medexus board’s medical and financial expertise, particularly in the United States ...
Medexus Secures Public Reimbursement for Cuvposa® in Quebec
01 févr. 2023 17h00 HE
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) wishes to inform investors that the company has reached an agreement with the...
Medexus Schedules Third Fiscal Quarter 2023 Conference Call
31 janv. 2023 17h00 HE
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, February 9,...
Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update
12 janv. 2023 07h30 HE
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce preliminary estimates of the company’s revenue results for...